Clinical Trials Browser

Phase 1/2 × Erlotinib Hydrochloride × Dermatologic × Clear all

NCT06483555 2026-04-23

PANGEA

Phase 1/2 Recruiting

DermatologicGastrointestinal

Pancreatic Neoplasms, Neoplasms, Basal Cell

NCT01465815 2014-11-19

Phase I/II Study of Postoperative Adjuvant Chemoradiation for Advanced-Stage Cutaneous Squamous Cell Carcinoma of the Head and Neck (cSCCHN)

Phase 1/2 Withdrawn

Skin Neoplasms